T
Thomas F. Lüscher
Researcher at University of Zurich
Publications - 1613
Citations - 88517
Thomas F. Lüscher is an academic researcher from University of Zurich. The author has contributed to research in topics: Endothelium & Myocardial infarction. The author has an hindex of 134, co-authored 1560 publications receiving 79034 citations. Previous affiliations of Thomas F. Lüscher include University of Texas Southwestern Medical Center & Durham University.
Papers
More filters
Journal ArticleDOI
Moving from impact to influence: measurement and the changing role of medical journals
TL;DR: While accurate and reliable measurement is a core principle of good science and the foundation for evaluating research, editors and scientific journals have often been less successful at applying similar standards to their own work—particularly in medicine.
Journal ArticleDOI
The potential for inappropriate ventricular tachycardia confirmation using the Intracardiac Electrogram (EGM) Width Criterion.
TL;DR: Evaluating the accuracy of the ECM width measurements during exercise testing with Medtronic Micro Jewel II Model 7223 ICDs found seven patients had inappropriately wide EGM width measurements, but did not satisfy the EGM Width Criterion.
Journal ArticleDOI
Macrophage NCOR1 protects from atherosclerosis by repressing a pro-atherogenic PPARγ signature
Sara Oppi,Stefanie Nusser-Stein,Przemyslaw Blyszczuk,Przemyslaw Blyszczuk,Xu Wang,A Jomard,A Jomard,Vincenzo Marzolla,Kangmin Yang,Srividya Velagapudi,Liam J. Ward,Xi-Ming Yuan,Martin Andreas Geiger,Ana Terezinha Guillaumon,Alaa Othman,Thorsten Hornemann,Zoran Rancic,Dongryeol Ryu,Maaike H. Oosterveer,Elena Osto,Elena Osto,Thomas F. Lüscher,Thomas F. Lüscher,Thomas F. Lüscher,Sokrates Stein +24 more
TL;DR: It is suggested that stabilizing the NCOR1-PPARγ binding could be a promising strategy to block the pro-atherogenic functions of plaque macrophages and lesion progression in atherosclerotic patients.
Journal ArticleDOI
Inhibition of Protein Kinase Cβ Prevents Foam Cell Formation by Reducing Scavenger Receptor A Expression in Human Macrophages
Elena Osto,Alexei Kouroedov,Pavani Mocharla,Alexander Akhmedov,Christian Besler,Lucia Rohrer,Arnold von Eckardstein,Sabino Iliceto,Massimo Volpe,Thomas F. Lüscher,Francesco Cosentino +10 more
TL;DR: Nonspecific inhibition of PKC&bgr; prevents LDL uptake in macrophages is suggested to represent a novel class of antiatherosclerotic drugs.
Journal ArticleDOI
Internal-mammary coronary artery grafts: is their superiority also due to a basically intact endothelium?
K H Lehmann,L. K. Von Segesser,Werner Dr. Müller-Glauser,Siebenmann R,Schneider K,Thomas F. Lüscher,M. I. Turina +6 more
TL;DR: It is concluded that long-term superiority of IMA grafts may also be due to the lack of primary intimal defects, which is similar to that of saphenous vein grafts.